S16 Ep28: Medical Crossfire®: Menin Inhibitors in AML—Dissecting the Data to Define the Role
Highlights from the PER® CME activity "Medical Crossfire®: Menin Inhibitors in AML—Dissecting the Data to Define the Role" — this podcast is not certified for credit. To participate in the full accredited activity and earn CME credit, use the link below.
In this podcast, experts Naval Daver, MD; Courtney DiNardo, MD; and Eunice Wang, MD; discuss the rationale for treatment with menin inhibitors—and the data showing their efficacy and safety—in acute myeloid leukemia (AML).
Earn CME credit by completing the full accredited activity (available through March 17, 2027)…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.